US Stock MarketDetailed Quotes
LXRX Lexicon Pharmaceuticals
- 0.715
- -0.005-0.71%
Trading Dec 31 12:59 ET
258.29MMarket Cap-0.97P/E (TTM)
0.740High0.701Low1.08MVolume0.707Open0.720Pre Close773.92KTurnover0.58%Turnover RatioLossP/E (Static)361.49MShares3.73052wk High1.45P/B132.69MFloat Cap0.62052wk Low--Dividend TTM185.71MShs Float344.750Historical High--Div YieldTTM5.48%Amplitude0.620Historical Low0.717Avg Price1Lot Size
Lexicon Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 980.25%1.75M | 419.56%1.65M | 4,608.33%1.13M | 766.19%1.2M | 2,407.14%702K | 315.38%162K | 805.71%317K | -35.14%24K | -53.36%139K | 100.00%28K |
| Operating revenue | 980.25%1.75M | 419.56%1.65M | 4,608.33%1.13M | 766.19%1.2M | 2,407.14%702K | 315.38%162K | 805.71%317K | -35.14%24K | -53.36%139K | 100.00%28K |
| Cost of revenue | 914.29%71K | 1,975.00%166K | 31K | 85K | 70K | 7K | 8K | 0 | 0 | 0 |
| Gross profit | 983.23%1.68M | 379.29%1.48M | 4,479.17%1.1M | 705.04%1.12M | 2,157.14%632K | 297.44%155K | 782.86%309K | 24K | -53.36%139K | 28K |
| Operating expense | 31.31%65.37M | 27.58%56.84M | 48.98%46.43M | 71.33%172.87M | 56.30%47.37M | 115.21%49.79M | 85.30%44.55M | 33.09%31.17M | 15.46%100.9M | 19.58%30.31M |
| Selling and administrative expenses | 22.85%39.59M | 30.61%39.19M | 67.50%32.06M | 137.05%113.98M | 99.69%32.61M | 156.25%32.23M | 180.82%30.01M | 125.42%19.14M | 48.67%48.08M | 84.59%16.33M |
| -General and administrative expense | ---- | ---- | 67.50%32.06M | ---- | ---- | ---- | ---- | 125.42%19.14M | ---- | ---- |
| Research and development costs | 46.83%25.78M | 21.33%17.64M | 19.51%14.37M | 11.49%58.89M | 5.62%14.76M | 66.32%17.56M | 8.87%14.54M | -19.43%12.03M | -4.05%52.82M | -15.28%13.98M |
| Operating profit | -28.33%-63.69M | -25.12%-55.35M | -45.57%-45.33M | -70.45%-171.75M | -54.36%-46.74M | -114.90%-49.63M | -84.28%-44.24M | -33.20%-31.14M | -15.70%-100.76M | -19.53%-30.28M |
| Net non-operating interest income expense | -25.06%-1.12M | 389.91%1.93M | -286.87%-3.06M | -353.46%-5.37M | -1,297.69%-3.02M | -206.16%-894K | -14.48%-664K | -725.00%-792K | -77.25%-1.18M | 23.13%-216K |
| Non-operating interest income | 14.61%3.44M | 219.14%4.14M | 83.09%1.88M | 384.46%7.73M | 170.80%2.4M | 425.35%3.01M | 953.66%1.3M | 7,250.00%1.03M | 1,091.04%1.6M | 6,235.71%887K |
| Non-operating interest expense | 17.00%4.56M | 12.81%2.21M | 171.72%4.95M | 371.26%13.1M | 391.48%5.42M | 351.27%3.9M | 178.81%1.96M | 1,555.45%1.82M | 246.63%2.78M | 273.90%1.1M |
| Other net income (expense) | ||||||||||
| Income before tax | -28.28%-64.81M | -18.98%-53.43M | -51.55%-48.4M | -73.74%-177.12M | -63.17%-49.76M | -116.04%-50.53M | -82.63%-44.9M | -36.03%-31.93M | -16.16%-101.94M | -19.07%-30.49M |
| Income tax | ||||||||||
| Net income | -28.28%-64.81M | -18.98%-53.43M | -51.55%-48.4M | -73.74%-177.12M | -63.17%-49.76M | -116.04%-50.53M | -82.63%-44.9M | -36.03%-31.93M | -16.16%-101.94M | -19.07%-30.49M |
| Net income continuous Operations | -28.28%-64.81M | -18.98%-53.43M | -51.55%-48.4M | -73.74%-177.12M | -63.17%-49.76M | -116.04%-50.53M | -82.63%-44.9M | -36.03%-31.93M | -16.16%-101.94M | -19.07%-30.49M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -28.28%-64.81M | -18.98%-53.43M | -51.55%-48.4M | -73.74%-177.12M | -63.17%-49.76M | -116.04%-50.53M | -82.63%-44.9M | -36.03%-31.93M | -16.16%-101.94M | -19.07%-30.49M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -28.28%-64.81M | -18.98%-53.43M | -51.55%-48.4M | -73.74%-177.12M | -63.17%-49.76M | -116.04%-50.53M | -82.63%-44.9M | -36.03%-31.93M | -16.16%-101.94M | -19.07%-30.49M |
| Basic earnings per share | 14.29%-0.18 | 22.73%-0.17 | -17.65%-0.2 | -29.03%-0.8 | -25.00%-0.2 | -61.54%-0.21 | -37.50%-0.22 | -6.25%-0.17 | -3.33%-0.62 | 5.88%-0.16 |
| Diluted earnings per share | 14.29%-0.18 | 22.73%-0.17 | -17.65%-0.2 | -29.03%-0.8 | -25.00%-0.2 | -61.54%-0.21 | -37.50%-0.22 | -6.25%-0.17 | -3.33%-0.62 | 5.88%-0.16 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data